pooled CV from MR vs. IR [Power / Sample Size]

posted by Yura – Belarus, 2018-01-19 11:05 (2279 d 11:57 ago) – Posting: # 18221
Views: 3,864

Hi Helmut
If in carrying out a two-stage design in the first stage with N = 20 subjects bioequivalence is shown, what should be done with the second stage? :confused:
Best regards

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,652 registered users;
49 visitors (0 registered, 49 guests [including 7 identified bots]).
Forum time: 00:02 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5